Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer: A Double Blind, Placebo Controlled, Phase II Randomized Controlled Trial

NCT05849129 is registered in ClinicalTrials.gov with The Canadian College of Naturopathic Medicine as lead sponsor.

NCT NCT05849129
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05849129 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer: A Double Blind, Placebo Controlled, Phase II Randomized Controlled Trial
Lead sponsor
The Canadian College of Naturopathic Medicine
Phase
Phase 2
Overall status
Terminated
Start date
October 1, 2024
Completion date
September 24, 2026
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer